PRYOR DANIEL A
Known title: EVP, Strategy & Business Dev.CIK: 0001205249
PRYOR DANIEL A's purchase track record
PRYOR DANIEL A has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/13/2025 | ENOV | $289K | +5.6% | -22.9% | +7.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ENOV | ▼ Sell | Open Market | 666 | $18K | 12/9/2025 | View on chart |
| ENOV | ▼ Sell | Open Market | 333 | $9K | 12/9/2025 | View on chart |
| ENOV | ▼ Sell | Open Market | 333 | $9K | 12/9/2025 | View on chart |
| ENOV | ▼ Sell | Open Market | 333 | $9K | 12/9/2025 | View on chart |
| ENOV | ▲ Buy | Open Market | 10,000 | $289K | 8/13/2025 | View on chart |
| ENOV | ▲ Buy | Grant | 24,137 | $0 | 3/7/2025 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 2,331 | $85K | 3/4/2025 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 4,998 | $193K | 2/28/2025 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 6,599 | $290K | 2/17/2025 | View on chart |
| ENOV | ▲ Buy | Grant | 13,793 | $0 | 2/17/2025 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 1,728 | $107K | 3/6/2024 | View on chart |
| ENOV | ▲ Buy | Grant | 16,121 | $0 | 3/4/2024 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 530 | $32K | 3/1/2024 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 1,200 | $72K | 3/1/2024 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 6,514 | $416K | 2/23/2024 | View on chart |
| ENOV | ▲ Buy | Grant | 13,616 | $0 | 2/22/2024 | View on chart |
| ENOV | ▼ Sell | Tax Withholding | 943 | $56K | 2/20/2024 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,898 | $109K | 3/6/2023 | View on chart |
| ENOV | ▲ Buy | Grant | 24,190 | $0 | 2/28/2023 | View on chart |
| ENOV | ▲ Buy | Grant | 7,862 | $0 | 2/28/2023 | View on chart |
| ENOV | ▼ Sell | Open Market | 5,716 | $321K | 2/27/2023 | View on chart |
| ENOV | ▲ Buy | Grant | 10,341 | $0 | 2/27/2023 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,113 | $61K | 2/23/2023 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,106 | $69K | 2/21/2023 | View on chart |
| ENOV | ▼ Sell | Open Market | 67,421 | $3.7M | 11/15/2022 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 67,421 | $3.0M | 11/15/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 3,463 | $135K | 3/7/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 31,274 | $1.3M | 2/28/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 2,024 | $85K | 2/25/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 62,821 | $0 | 2/25/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,866 | $78K | 2/23/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 11,724 | $0 | 2/17/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 556 | $29K | 11/8/2021 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 556 | $29K | 11/8/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 90 | $5K | 11/5/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,154 | $62K | 11/5/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 6,045 | $328K | 11/5/2021 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 7,289 | $379K | 11/5/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 300 | $16K | 11/4/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 12,955 | $701K | 11/4/2021 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 16,616 | $864K | 11/4/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 3,361 | $180K | 11/4/2021 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 6,340 | $330K | 11/2/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 6,340 | $336K | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Enovis joins AAOS Registry Program as industry sponsor
Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.
Enovis joins AAOS Registry Program as industry sponsor. Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.